The Relationship between Leptin Levels and Continuous Positive Airway Pressure Treatment: A Cluster Analysis
- PMID: 38846593
- PMCID: PMC11152640
- DOI: 10.1055/s-0043-1777779
The Relationship between Leptin Levels and Continuous Positive Airway Pressure Treatment: A Cluster Analysis
Abstract
Objective Leptin is an appetite-suppressing hormone released by adipose tissue that plays an important role in severe obstructive sleep apnea syndrome (OSAS). However, it is unclear whether leptin levels are a useful biomarker for this syndrome. The present study aimed to assess the effect of continuous positive airway pressure (CPAP) treatment on the syndrome according to leptin levels, using a cluster classification based on clinical features of the syndrome. Materials and Methods We performed a hierarchical cluster analysis of data from 97 OSAS patients diagnosed via polysomnography. We also evaluated the effect after 6 months of CPAP administration. Results Clusters 1 (49 patients; 50.5%) and 2 (6 patients; 6.2%) presented normal leptin levels, and clusters 3 (11 patients; 11.3%) and 4 (31 patients; 32%) presented high leptin levels. Clusters 3 and 4 presented different leptin levels, but the same degree of obesity. After treatment, the levels of excessive daytime sleepiness improved in all clusters. In Cluster 3, leptin levels were significantly reduced after treatment. Conclusion Using the conventional diagnostic method of the apnea-hypopnea index, it was not clear whether leptin is a useful biomarker for the CPAP treatment. However, it may be helpful for particular clusters, including obese women, and where particular populations require CPAP treatment.
Keywords: cluster analysis; continuous positive airway pressure; leptin; obstructive sleep apnea; phenotype.
Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Conflict of interest statement
Conflict of Interests The authors have no conflict of interests to declare.
References
-
- Sateia M J. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(05):1387–1394. - PubMed
-
- Gami A S, Olson E J, Shen W K et al.International classification of sleep disorders (third edition): highlights and modifications. J Am Coll Cardiol. 2013;62(07):610–616. - PubMed
-
- Caples S M, Anderson W M, Calero K, Howell M, Hashmi S D. Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement. J Clin Sleep Med. 2021;17(06):1287–1293. - PMC - PubMed
-
- SAVE Investigators and Coordinators . McEvoy R D, Antic N A, Heeley E et al.CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–931. - PubMed
-
- Balcan B, Thunström E, Yucel-Lindberg T, Lindberg K, Ay P, Peker Y. Impact of CPAP treatment on leptin and adiponectin in adults with coronary artery disease and nonsleepy obstructive sleep apnoea in the RICCADSA trial. Sleep Med. 2020;67:7–14. - PubMed
LinkOut - more resources
Full Text Sources